AlzeCure Pharma (ALZCUR) — Free Cash Flow Generation Index

Latest as of March 2023: 1.00x

AlzeCure Pharma (ALZCUR) has a Free Cash Flow Generation Index of 1.00x as of March 2023. Free cash flow of Skr28.09 Million represents 1% of operating cash flow (Skr28.09 Million). See how liquid is AlzeCure Pharma's working capital to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

Skr28.09 Million
SEK

Operating Cash Flow

Skr28.09 Million
SEK

Capital Expenditures

Skr0.00
SEK

AlzeCure Pharma Free Cash Flow Generation Index (2023–2023)

Historical FCF Generation Index trend for AlzeCure Pharma across 1 annual periods. Explore ALZCUR cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for AlzeCure Pharma (2023–2023)

Year-by-year Free Cash Flow Generation Index for AlzeCure Pharma. For the full company profile including market capitalisation, see market cap of AlzeCure Pharma.

Year FCG Index Free Cash Flow (SEK) Operating CF Capital Expenditures YoY Change
2023 1.00x Skr3.06 Million Skr3.06 Million Skr0.00 —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).